1-3 of 3
Akeem Yusuf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib 56mg/m2 Twice-Weekly in Combination with Dexamethasone and Daratumumab (KdD) Versus Daratumumab in Combination with 8 Cycles of Bortezomib and Dexamethasone (DVd); A Matching-Adjusted Indirect Treatment Comparison

Katja Weisel, MD, Ajay Nooka, MDMPH, Evangelos Terpos, MDPhD, Andrew Spencer, Hartmut Goldschmidt, MD, Istvan Majer, PhD, Lucy DeCosta, MSc, Rohan Medhekar, PhD, Akeem Yusuf, PhD BPharm, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-141995
Published: 2020
Journal Articles

Efficacy and Safety of Carfilzomib-Lenalidomide-Dexamethasone (KRd) in Newly Diagnosed Multiple Myeloma: Pooled Analysis of 4 Single-Arm Studies

Ola Landgren, MD PhD, Michel Attal, MD PhD, Dickran Kazandjian, MD, Murielle Roussel, MD, Jagoda K. Jasielec, MD, Dominik Dytfeld, Aparna Anderson, Tara Kervin, Karim Iskander, Khalid Mezzi, Tim Welliver, Akeem Yusuf, PhD BPharm, Andrzej Jakubowiak, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1891.
https://doi.org/10.1182/blood-2019-127076
Published: 2019
Journal Articles

Treatment Sequencing Patterns in Medicare-Enrolled Patients with Multiple Myeloma

Shuling Li, PhD, Tanya Natwick, Akeem Yusuf, Irena Sarah Vidito, Khalid Mezzi, Winifred Werther
Journal: Blood
Blood (2016) 128 (22): 2120.
https://doi.org/10.1182/blood.V128.22.2120.2120
Published: 2016